Clostridium difficile infections are one of the major public health problems that is persistent and growing globally. The present treatment of these infections is restricted to vancomycin, metronidazole and fidaxomicin.  There is an urgent need for new anti-clostridial drugs because the antibiotic choices have become limited due to increasing resistance. …